NAT-ABIRATERONE

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: f2d1bdc84d18ef50
Drug Approval Canada Name: NAT-ABIRATERONE
Product Name: NAT-ABIRATERONE
Status: Marketed
Status Date: 2021-01-18
Original Market Date: 2021-01-18
Din: 02494132
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L02BX03 ABIRATERONE
Atc Name: l 02 bx 03
Aig Number: 0152948001
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

ABIRATERONE ACETATE

250 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f2d1bdc84d18ef50

Type

Standard